title: Species-specific properties and translational aspects of canine dendritic cells.
abstract: Dogs are affected by spontaneously occurring neoplastic and inflammatory diseases which often share many similarities with pathological conditions in humans and are thus appreciated as important translational animal models. Dendritic cells (DCs) represent the most potent antigen presenting cell population. Besides their physiological function in the initiation of primary T cell responses and B cell immunity, a deregulation of DC function is involved in immune-mediated tissue damage, immunosuppression and transplantation complication in human and veterinary medicine. DCs represent a promising new target for cancer immunotherapy in dogs. However, the therapeutic use of canine DCs is restricted because of a lack of standardized isolation techniques and limited information about dog-specific properties of this cell type. This article reviews current protocols for the isolation and in vitro generation of canine monocyte- and bone marrow-derived DCs. DCs of dogs are characterized by unique morphological features, such as the presence of cytoplasmic projections and periodic microstructures. Canine DCs can be discriminated from other hematopoietic cells also based on phenotypic properties and their high T cell stimulatory capability in mixed leukocyte reactions. Furthermore, the classification of canine DC-derived neoplasms and the role of DCs in the pathogeneses of selected infectious, allergic and autoimmune diseases, which share similarities with human disorders, are discussed. Future research is needed to expand the existing knowledge about DC function in canine diseases as a prerequisite for the development of future therapies interfering with the immune response.
authors.affiliation: Department of Pathology, University of Veterinary Medicine, Hannover, Bünteweg 17, 30559 Hannover, Germany.
authors.forename: V
authors.initials: V
authors.lastname: Qeska
authors.forename: W
authors.initials: W
authors.lastname: Baumgärtner
authors.forename: A
authors.initials: A
authors.lastname: Beineke
mesh_terms: D000818:Animals; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use; D019070:Cell Lineage / Q000276:immunology; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology*; D004283:Dog Diseases / Q000276:immunology; D004285:Dogs / Q000276:immunology*; D006801:Humans; D007154:Immune System Diseases / Q000276:immunology / Q000662:veterinary; D007167:Immunotherapy / Q000662:veterinary; D007239:Infections / Q000276:immunology / Q000662:veterinary; D008213:Lymphocyte Activation; D023421:Models, Animal; D009369:Neoplasms / Q000276:immunology / Q000628:therapy / Q000662:veterinary; D010587:Phagocytosis; D013045:Species Specificity; D013601:T-Lymphocytes / Q000276:immunology; D057170:Translational Research, Biomedical
chemical_list: D019496:Cancer Vaccines; D016207:Cytokines